RM Primary Logo - Humble.png
Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024
July 08, 2024 16:05 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Logo.jpg
Memo Therapeutics AG appoints Paul Carter as Chairperson
July 08, 2024 07:00 ET | Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public...
Logo.jpg
Memo Therapeutics AG appoints Paul Carter as Chairperson
July 08, 2024 02:00 ET | Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public and...
AIMLogo.jpg
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
July 03, 2024 08:55 ET | AIM ImmunoTech Inc.
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company’s...
Picture1.png
Scientific Presentations Highlight OGM’s Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations
July 02, 2024 08:00 ET | Bionano Laboratories
At a sponsored workshop, Su Yang from The University of Texas MD Anderson Cancer Center will present case studies that demonstrate the ability of the optical genome mapping (OGM) workflow to detect...
Picture1.png
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
@Birdeyecam_DJI_0163_BD (1)
The children of Voiles de l’Espoir at the Yacht Club de Monaco
June 21, 2024 12:29 ET | Yacht Club de Monaco
TURIN, Italy, June 21, 2024 (GLOBE NEWSWIRE) -- A stopover at the Yacht Club de Monaco and in the heart of the Principality. A hundred children in remission from cancer and leukaemia aboard 50 boats...
Macomics.jpg
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
June 19, 2024 04:00 ET | Macomics Limited
Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloid-derived suppressor cells in prostate cancer...
Mika Health Logo Color.png
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment
June 18, 2024 13:36 ET | MIKA Health
Breast cancer patients access AI-enabled mobile digital therapeutic to supplement pharmaceutical therapy.
cgoncology_cover.jpg
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
June 18, 2024 08:00 ET | CG Oncology Inc.
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec